[{"Physician_Profile_ID": "637065", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Merck Sharp & Dohme Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000053", "Total_Amount_of_Payment_USDollars": "496.60", "Date_of_Payment": "11/06/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "24484181", "Name_of_Associated_Covered_Drug_or_Biological1": "JANUMET", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "A Phase III, Multicenter, Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-0431A A Fixed-Dose Combination Tablet of Sitagliptin and Metformin in", "Research_Information_Link": "", "Context_of_Research": ""}]